We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigating the Neurobiology of Tinnitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01294124
Recruitment Status : Completed
First Posted : February 11, 2011
Last Update Posted : December 16, 2019
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Washington University School of Medicine

Tracking Information
First Submitted Date February 9, 2011
First Posted Date February 11, 2011
Last Update Posted Date December 16, 2019
Actual Study Start Date May 25, 2016
Actual Primary Completion Date July 12, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: February 10, 2011)
Development of Tinnitus [ Time Frame: Post-deployment assessment will occur no sooner than 90 days from return from active military theater. ]
The presence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: February 10, 2011)
  • Mild Traumatic Brain Injury [ Time Frame: Post-deployment assessment will occur no sooner than 90 days from return from active military theater. ]
    Mild Traumatic Brain Injury - Ohio State University TBI Identification Method (OSU TBI-ID version 12-10-08)(Corrigan and Bogner 2007)
  • Post Traumatic Stress Disorder [ Time Frame: Post-deployment assessment will occur no sooner than 90 days from return from active military theater. ]
    Subjects whose military medical record or PDHA suggests PTSD will be asked to complete the Clinician Administered PTSD Scale (CAPS).(Blake et al. 1995; Weathers and Litz 1994)
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Investigating the Neurobiology of Tinnitus
Official Title Investigating The Neurobiology of Tinnitus
Brief Summary

The investigators hypothesize that individual differences exist in resting-state cortical attention, control, sensory, and emotion networks prior to noise exposure and these differences predispose some to the development of bothersome tinnitus. Furthermore, the investigators hypothesize that these changes in functional connectivity of these vulnerable systems after noise exposure are responsible for tinnitus. The proposed study will use a case-control cohort study design. Cases will be those soldiers who develop tinnitus and controls will be those who do not. This will be the first prospective study of tinnitus and will provide important information about the neurobiology of tinnitus.

If a cortical neural network etiology for bothersome tinnitus is confirmed, it will be an astounding, powerful, paradigm shifting model for the diagnosis, prevention and, most importantly, treatment of tinnitus. Furthermore, if a battery of neurocognitive tests can identify soldiers at risk for the development of tinnitus then appropriate primary prevention strategies can be introduced.

There are three Specific Aims to this project.

Specific Aim 1. To determine if soldiers who develop tinnitus display pre-deployment differences in a set of physical, functional, cognitive, vulnerability, perpetuating factors, pre-deployment neurocognitive scores, or neuroimaging features compared to soldiers who do not develop tinnitus ("control group").

Specific Aim 2. To determine if particular scores on neurocognitive tests or neuroimaging features of functional/structural connectivity networks are associated with the development of tinnitus.

Specific Aim 3. To identify a set of pre-deployment physical, functional, cognitive, vulnerability, and perpetuating factors, neurocognitive responses, and neuroimaging features that are associated with the development of tinnitus.

The investigators plan to recruit 200 soldiers, between the ages of 18 and 30 years who do not have hearing loss or tinnitus and have never been deployed to military theater. The soldier participants will undergo a variety of tests before and after deployment, which will include a hearing test, neurocognitive tests (i.e., brain function tests), and a variety of novel radiologic imaging studies of the brain. One of these novel radiologic imaging studies is functional connectivity Magnetic Resonance Imaging, a proven methodology that monitors changes in brain activity and connections based on blood flow between different brain areas and levels of consumption of oxygen. This information is used to describe the condition of important neural networks responsible for such things as attention, mood, sensation, vision, hearing, and introspection or self-contemplation.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Active-duty or reserve United States military personnel between the ages of 18 and 30 of either sex, all races and ethnicity, who are scheduled for initial deployment to theater with a Military Occupational Specialty code (MOS) of 11B Infantryman, 11C Indirect Fire Infantryman, 19D Calvary Scout, or 19K Armor Crewman.
Condition
  • Tinnitus
  • Traumatic Brain Injury
  • Post Traumatic Stress Disorder
Intervention Not Provided
Study Groups/Cohorts
  • No Tinnitus
    The absence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).
  • Tinnitus
    The presence of tinnitus will be based on the participants' responses to questions 8a, 9c, and 9d of the Post-Deployment Health Assessment (PDHA).
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: May 21, 2019)
218
Original Estimated Enrollment
 (submitted: February 10, 2011)
200
Actual Study Completion Date July 12, 2019
Actual Primary Completion Date July 12, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Active duty or reserve military personnel with MOS job code 11B, 11C, 19D, or 19K
  • Men and women between the ages of 18 and 30 years
  • Scheduled for first deployment to military theater
  • Must be able to read, write, and understand English
  • Willing to sign Request Pertaining to Military Records (Form 180) to allow study personnel to access medical records for the purposes of this study.

Exclusion Criteria:

  • History of hearing loss or tinnitus
  • Currently taking medication for depression, anxiety, or other DSM IV Axis 1 disorder
  • History of head trauma sufficient to cause loss of consciousness for 30 minutes or greater
  • History of surgery to the brain
  • History of claustrophobia
  • Presence of metallic implants in the head and upper cervical region that are non-MRI compatible and would prohibit use of MRI.
  • At any time in the past, prior deployment or employment in military theater
  • Currently pregnant
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 30 Years   (Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT01294124
Other Study ID Numbers NMCSD.2013.0021
CDMRP ( Other Grant/Funding Number: DM102565 )
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Current Responsible Party Washington University School of Medicine
Original Responsible Party Jay F. Piccirillo, MD/ Professor, Washington University School of Medicine
Current Study Sponsor Washington University School of Medicine
Original Study Sponsor Same as current
Collaborators United States Department of Defense
Investigators
Principal Investigator: Jay F. Piccirillo, MD Washington University School of Medicine
Principal Investigator: Sean Wise, CAPT., M.D. United States Naval Medical Center, San Diego
PRS Account Washington University School of Medicine
Verification Date December 2019